Lesson 15 - New Treatments for Sepsis

By Mark Forshag, MD, FCCP

Read/Print This Document
Poststudy Questions

Dr. Forshag is Clinical Associate Professor of Medicine, Medical Director of the MICU, Department of Internal Medicine, Carolinas Medical Center, Charlotte, North Carolina.

Dr. Forshag has disclosed significant relationships with the following
companies/organizations whose products or services may be discussed within this chapter: Eli Lilly and Company.

Lesson 16 - Nocardia Pulmonary Infections

By Marcos I. Restrepo, MD; and Stephen Jenkinson, MD, FCCP

Read/Print This Document
Poststudy Questions

Dr. Restrepo is a Clinical Fellow, Divisions of Pulmonary/Critical Care Medicine and Infectious Diseases, Department of Medicine, and Dr. Jenkinson is Professor, Division of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Texas Health Science Center at San Antonio, Texas.

The authors have disclosed no significant relationships with the companies/organizations whose products or services may be discussed within this chapter.

---

Editor-in-Chief:
GARY R. EPLER, MD, FCCP
Boston, Massachusetts

Deputy Editor:
STEVEN A. SAHN, MD, FCCP
Charleston, South Carolina

ACCP Staff:
ALVIN LEVER
Executive Vice President and CEO

ED DELLERT
Vice President of Education Resources

ARLENE KARAVICH
PCCU Program Coordinator

AMY REYNALDO
Copy Editor

Accreditation Statement
The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American College of Chest Physicians takes responsibility for the content, quality, and scientific integrity of this CME activity.

CME Credit
The ACCP designates this continuing medical education activity for up to 24 credit hours (1 credit per lesson) in Category 1 of the Physician’s Recognition Award of the American Medical Association.